Sarcomeric restrictive cardiomyopathy (Q96352): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 12:19, 16 August 2026
Sarcomeric restrictive cardiomyopathy is the presence of restrictive cardiomyopathy in the presence of a sarcomeric gene mutation that is known to be significantly associated with restrictive physiology. Additional information. Examples include: Mutations in myosin-binding protein (MYBPC3), β-myosin heavy chain (MYH7), myosin light chain genes (MYL3), troponin I (TNNI3), and troponin T (TNNT2).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1129643783 |
||
| English | Sarcomeric restrictive cardiomyopathy |
Sarcomeric restrictive cardiomyopathy is the presence of restrictive cardiomyopathy in the presence of a sarcomeric gene mutation that is known to be significantly associated with restrictive physiology. Additional information. Examples include: Mutations in myosin-binding protein (MYBPC3), β-myosin heavy chain (MYH7), myosin light chain genes (MYL3), troponin I (TNNI3), and troponin T (TNNT2). |
Statements
CID11:ID_1129643783
0 references
dki-india-ID_1129643783
0 references
Concluído
0 references
15 August 2026
0 references
